Literature DB >> 28819711

Measurement invariance, the lack thereof, and modeling change.

Michael C Edwards1,2, Carrie R Houts3, R J Wirth3.   

Abstract

PURPOSE: Measurement invariance issues should be considered during test construction. In this paper, we provide a conceptual overview of measurement invariance and describe how the concept is implemented in several different statistical approaches. Typical applications look for invariance over things such as mode of administration (paper and pencil vs. computer based), language/translation, age, time, and gender, to cite just a few examples. To the extent that the relationships between items and constructs are stable/invariant, we can be more confident in score interpretations.
METHODS: A series of simulated examples are reported which highlight different kinds of non-invariance, the impact it can have, and the effect of appropriately modeling a lack of invariance. One example focuses on the longitudinal context, where measurement invariance is critical to understanding trends over time. Software syntax is provided to help researchers apply these models with their own data.
RESULTS: The simulation studies demonstrate the negative impact an erroneous assumption of invariance may have on scores and substantive conclusions drawn from naively analyzing those scores.
CONCLUSIONS: Measurement invariance implies that the links between the items and the construct of interest are invariant over some domain, grouping, or classification. Examining a new or existing test for measurement invariance should be part of any test construction/implementation plan. In addition to reviewing implications of the simulation study results, we also provide a discussion of the limitations of current approaches and areas in need of additional research.

Keywords:  DIF; IRT; Measurement invariance; Psychometrics

Mesh:

Year:  2017        PMID: 28819711     DOI: 10.1007/s11136-017-1673-7

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  18 in total

1.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-10       Impact factor: 5.725

2.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-13       Impact factor: 5.725

Review 3.  Different approaches to differential item functioning in health applications. Advantages, disadvantages and some neglected topics.

Authors:  Jeanne A Teresi
Journal:  Med Care       Date:  2006-11       Impact factor: 2.983

Review 4.  Guidelines for reporting results of quality of life assessments in clinical trials.

Authors:  M Staquet; R Berzon; D Osoba; D Machin
Journal:  Qual Life Res       Date:  1996-10       Impact factor: 4.147

5.  Differential Item Functioning (DIF) and Subsequent Bias in Group Comparisons using a Composite Measurement Scale: A Simulation Study.

Authors:  Alexandra Rouquette; Jean-Benoit Hardouin; Joel Coste
Journal:  J Appl Meas       Date:  2016

Review 6.  A review of empirical research related to the use of small quantitative samples in clinical outcome scale development.

Authors:  Carrie R Houts; Michael C Edwards; R J Wirth; Linda S Deal
Journal:  Qual Life Res       Date:  2016-07-13       Impact factor: 4.147

7.  Factorial Invariance within Longitudinal Structural Equation Models: Measuring the Same Construct across Time.

Authors:  Keith F Widaman; Emilio Ferrer; Rand D Conger
Journal:  Child Dev Perspect       Date:  2010-04-01

8.  Confirmatory factor analysis and item response theory: two approaches for exploring measurement invariance.

Authors:  Steven P Reise; Keith F Widaman; Robin H Pugh
Journal:  Psychol Bull       Date:  1993-11       Impact factor: 17.737

Review 9.  Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report.

Authors:  Margaret Rothman; Laurie Burke; Pennifer Erickson; Nancy Kline Leidy; Donald L Patrick; Charles D Petrie
Journal:  Value Health       Date:  2009-09-25       Impact factor: 5.725

Review 10.  Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards.

Authors:  Michael Brundage; Jane Blazeby; Dennis Revicki; Brenda Bass; Henrica de Vet; Helen Duffy; Fabio Efficace; Madeleine King; Cindy L K Lam; David Moher; Jane Scott; Jeff Sloan; Claire Snyder; Susan Yount; Melanie Calvert
Journal:  Qual Life Res       Date:  2012-09-18       Impact factor: 4.147

View more
  3 in total

1.  Introduction to special section: test construction.

Authors:  Muirne C S Paap; Jan R Böhnke; Carolyn E Schwartz; Frans J Oort
Journal:  Qual Life Res       Date:  2018-07       Impact factor: 4.147

2.  Work Engagement among Rescue Workers: Psychometric Properties of the Portuguese UWES.

Authors:  Jorge Sinval; Alexandra Marques-Pinto; Cristina Queirós; João Marôco
Journal:  Front Psychol       Date:  2018-01-22

3.  Measurement invariance of six language versions of the post-traumatic stress disorder checklist for DSM-5 in civilians after traumatic brain injury.

Authors:  Fabian Bockhop; Marina Zeldovich; Katrin Cunitz; Dominique Van Praag; Marjolein van der Vlegel; Tim Beissbarth; York Hagmayer; Nicole von Steinbuechel
Journal:  Sci Rep       Date:  2022-10-04       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.